Can primaquine therapy for vivax malaria be improved?
The incidence and range of endemic malaria caused by Plasmodium vivax has expanded during the past 30 years. This parasite forms hypnozoites in the liver, creating a persistent reservoir of infection. Primaquine (PQ), introduced 50 years ago, is the only drug available to eliminate hypnozoites. Howe...
Hlavní autoři: | Baird, J, Rieckmann, K |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2003
|
Podobné jednotky
-
Therapeutic principles of primaquine against relapse of Plasmodium vivax malaria
Autor: Baird, J
Vydáno: (2018) -
Primaquine as anti-relapse therapy for Plasmodium vivax
Autor: Baird, J
Vydáno: (1998) -
Primaquine therapy for malaria.
Autor: Baird, J, a další
Vydáno: (2004) -
High-dose primaquine regimens against relapse of Plasmodium vivax malaria.
Autor: Krudsood, S, a další
Vydáno: (2008) -
Treatment of primaquine-resistant Plasmodium vivax malaria.
Autor: Luzzi, G, a další
Vydáno: (1992)